Gitnux/Report 2026

Long Term Sobriety Statistics

The latest U.S. figures show 15.6 million people aged 12 or older used illicit drugs in the past month in 2023, yet the same evidence base points to concrete, measurable ways treatment and recovery supports can change the odds. From medication for opioid use disorder cutting all-cause mortality by about 50% to contingency management and extended-release naltrexone boosting opioid-free days, this page shows what keeps long-term sobriety within reach when relapse risk stays high at 40% to 60% in the first year.
29Statistics
29Sources
6Sections
1Visuals
7mRead
17 days agoUpdated
Long Term Sobriety Statistics
Verified via a 4-step process
01Source

Data aggregated from peer-reviewed journals, government agencies, and professional bodies with disclosed methodology and sample sizes.

02Verify

Each statistic is independently verified via reproduction analysis and cross-referencing against independent databases.

03Grade

Figures are graded by cross-model consensus. Statistics failing independent corroboration are excluded regardless of how widely cited.

04Cite

Every figure carries a primary source. We maintain stable URLs and versioned verification dates so the report can be cited.

Read our full methodology →

Statistics that fail independent corroboration are excluded.

Next review Dec 2026
Over 15 million Americans reported recent illicit drug use last year. Medication can cut the risk of death from opioid addiction by half. These statistics show both the scale of substance use and the effectiveness of certain recovery paths.

Key Takeaways

  • 15.6 million people aged 12 or older reported using illicit drugs in the past month in the United States in 2023 (6.7% of the U.S. population aged 12+)
  • 24.6% of U.S. adults reported heavy alcohol use in 2022
  • In the United States, there are 3.5 million people aged 12 or older with Opioid Use Disorder in 2023 (estimated prevalence 1.4%)
  • In 2022, 57.2% of adults who reported binge drinking did not receive alcohol use disorder treatment
  • A CDC review found that screening and brief interventions can reduce risky drinking by about 10–20% compared with control conditions
  • In 2022, the National Survey on Drug Use and Health estimated that 2.5 million people aged 12 or older had a substance use disorder but did not receive treatment
  • The U.S. 2024 CARE Act includes expanded requirements for evidence-based coverage of substance use disorder treatment and recovery supports through health plans
  • SAMHSA-funded Certified Community Behavioral Health Clinics (CCBHCs) provide coverage-linked and comprehensive services for mental health and substance use disorders, including care coordination and same-day access
  • Opioid use disorder treatment with medication is associated with a 2-fold increase in treatment retention compared with treatment without medication
  • Meta-analysis shows that medication for opioid use disorder is associated with approximately a 50% reduction in all-cause mortality compared with no medication
  • A 2020 systematic review reported that contingency management interventions can achieve abstinence rates roughly 2–3 times higher than control conditions for substance use disorders
  • In 2021, 63% of U.S. adults said they would be willing to talk to someone about addiction
  • A 2017 systematic review found that stigma toward substance use disorders is associated with reduced treatment-seeking and worse recovery outcomes
  • In a 2019 study, 1 in 3 people with opioid use disorder reported discrimination when seeking treatment
  • Narcotics Anonymous (NA) maintains a worldwide fellowship with meetings in many countries; NA World Services reports thousands of groups worldwide (as reported in their world services documentation)

Millions struggle with addiction, but evidence shows medications, counseling, and recovery supports can greatly improve outcomes.

02 · Category

Prevention & Risk5 stats

01
In the United States, there are 3.5 million people aged 12 or older with Opioid Use Disorder in 2023 (estimated prevalence 1.4%)
02
In 2022, 57.2% of adults who reported binge drinking did not receive alcohol use disorder treatment
03
A CDC review found that screening and brief interventions can reduce risky drinking by about 10–20% compared with control conditions
04
In the U.S., 45.6% of adults who reported past-year misuse of prescription pain relievers obtained them from friends/relatives or other non-medical sources
05
A 2020 systematic review found that recovery support services (e.g., case management, peer recovery support, recovery coaching) are associated with improved recovery outcomes compared with usual care
Interpretation

Prevention & Risk Interpretation

For the Prevention and Risk angle, the data show that opioid use disorder affects an estimated 1.4% of the US population aged 12 or older, while large treatment gaps persist such as 57.2% of adults who binge drink not receiving alcohol use disorder treatment, and evidence that screening and brief interventions can cut risky drinking by about 10 to 20%.

03 · Category

Industry & Policy3 stats

01
In 2022, the National Survey on Drug Use and Health estimated that 2.5 million people aged 12 or older had a substance use disorder but did not receive treatment
02
The U.S. 2024 CARE Act includes expanded requirements for evidence-based coverage of substance use disorder treatment and recovery supports through health plans
03
SAMHSA-funded Certified Community Behavioral Health Clinics (CCBHCs) provide coverage-linked and comprehensive services for mental health and substance use disorders, including care coordination and same-day access
Interpretation

Industry & Policy Interpretation

From the 2.5 million U.S. adults and teens with a substance use disorder in 2022 to the U.S. CARE Act’s 2024 push for evidence-based coverage and SAMHSA’s expansion through Certified Community Behavioral Health Clinics, policy and industry action are clearly aligning to broaden access to long term recovery supports.

04 · Category

Treatment & Recovery6 stats

01
Opioid use disorder treatment with medication is associated with a 2-fold increase in treatment retention compared with treatment without medication
02
Meta-analysis shows that medication for opioid use disorder is associated with approximately a 50% reduction in all-cause mortality compared with no medication
03
A 2020 systematic review reported that contingency management interventions can achieve abstinence rates roughly 2–3 times higher than control conditions for substance use disorders
04
In a 2021 randomized clinical trial, patients receiving extended-release naltrexone had significantly higher proportions of opioid-free days during treatment than those receiving placebo
05
Relapse is common: 40%–60% of people treated for substance use disorders relapse within 1 year, with many relapses occurring in the first year
06
A 2012–2019 study in JAMA Psychiatry found that individuals with substance use disorders who receive medication for opioid use disorder have lower overdose death rates than those without medication
Interpretation

Treatment & Recovery Interpretation

In the Treatment and Recovery category, the evidence suggests that longer lasting sobriety is strongly supported by evidence based approaches, since medications for opioid use disorder double treatment retention and are linked to about a 50% reduction in all cause mortality, while relapse remains common as 40% to 60% of people relapse within one year.

05 · Category

Attitudes & Stigma4 stats

01
In 2021, 63% of U.S. adults said they would be willing to talk to someone about addiction
02
A 2017 systematic review found that stigma toward substance use disorders is associated with reduced treatment-seeking and worse recovery outcomes
03
In a 2019 study, 1 in 3 people with opioid use disorder reported discrimination when seeking treatment
04
In a 2021 study, people with substance use disorder who reported higher perceived stigma had higher odds of relapse
Interpretation

Attitudes & Stigma Interpretation

For the Attitudes & Stigma angle, the evidence suggests that stigma is not just a social issue but a recovery risk, with 1 in 3 people with opioid use disorder reporting discrimination when seeking treatment and a 2021 study showing higher perceived stigma was linked to higher odds of relapse.

06 · Category

Recovery Ecosystem9 stats

01
Narcotics Anonymous (NA) maintains a worldwide fellowship with meetings in many countries; NA World Services reports thousands of groups worldwide (as reported in their world services documentation)
02
Peer recovery support services are listed by SAMHSA as a key component of recovery-oriented systems of care
03
The U.S. National Recovery Month (SAMHSA) highlights recovery supports and evidence-based recovery practices nationwide every September
04
The Global Burden of Disease study estimated that alcohol use disorders contributed millions of disability-adjusted life years (DALYs), reflecting the scale of alcohol-related harm
05
A 2020 cohort study in JAMA Network Open found that participation in recovery housing was associated with increased treatment adherence and recovery support engagement
06
Recovery housing research reports substantial reductions in days of substance use among residents engaged in recovery housing programs compared with controls
07
In the UK, structured aftercare following treatment is associated with reduced relapse risk; a 2020 review reported lower relapse rates among participants receiving aftercare than those without aftercare
08
A randomized trial found that patients receiving telephone-based recovery support had higher abstinence rates than control at follow-up (abstinence differences were statistically significant)
09
A 2016 meta-analysis found that intensive outpatient treatment (IOP) can reduce substance use outcomes compared with less intensive approaches
Interpretation

Recovery Ecosystem Interpretation

The Recovery Ecosystem is strengthening in measurable ways, with global peer support like Narcotics Anonymous operating worldwide, U.S. SAMHSA positioning peer recovery services and National Recovery Month each year, and 2020 JAMA Network Open findings showing recovery housing supports can improve treatment adherence, all backed by research documenting substantial reductions in substance use days among participants.
report visual · Comparison

Long-Term Recovery: Key Signals and Outcomes

Long-term sobriety is supported by evidence-based treatment and recovery supports, while treatment gaps and relapse risk remain major challenges.

In 2022, 57.2% of adults who reported binge drinking did not receive alcohol use disorder treatment57.2%
Meta-analysis shows that medication for opioid use disorder is associated with approximately a 50% reduction in all-caus
50%
Relapse is common: 40%–60% of people treated for substance use disorders relapse within 1 year, with many relapses occur
40%
source-verifiedncbi.nlm.nih.gov · jamanetwork.com · samhsa.gov2022
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Elif Demirci. (2026, February 13). Long Term Sobriety Statistics. Gitnux. https://gitnux.org/long-term-sobriety-statistics
MLA
Elif Demirci. "Long Term Sobriety Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/long-term-sobriety-statistics.
Chicago
Elif Demirci. 2026. "Long Term Sobriety Statistics." Gitnux. https://gitnux.org/long-term-sobriety-statistics.

Sources & references

29 datasets cited across this report · attribution is report-level

+20 additional datasets cited (not shown individually)